News Terpenes in ‘nanocarriers’ may work better than traditional painkillers: study The volatile compounds do more than just smell good Natalia Buendia CalvilloMarch 29, 2022
News Therapists’ personal experience important for patients undergoing psilocybin-assisted therapy: study Previous experience was rated more important than shared symptoms, gender or ethnicity Natalia Buendia CalvilloMarch 28, 2022
Canada Pandemic not responsible for rising pot sales in Canada: study But the data fails to account for the impact of the illicit market Nick LabaMarch 25, 2022
Cannabis Cannabis eases muscle spasms, lowers pain and improves sleep in MS patients: study Existing data is promising, but researchers urge more human trials be done Natalia Buendia CalvilloMarch 24, 2022
Business Universal Ibogaine hires ex-Canopy research director ahead of clinical trial application The firm owns rights to a treatment protocol used at a popular clinic in Cancun, Mexico Natalia Buendia CalvilloMarch 23, 2022
Policy Policy group spotlights 19 US states where cannabis reform still lags Cannabis prohibition today is outdated, unjust and inhumane, the Marijuana Policy Project says in a new report Nick LabaMarch 22, 2022
Business CBD relieves menstruation symptoms: Canopy-sponsored clinical trial Researchers note that treatment targeted at the start of symptoms was effective Natalia Buendia CalvilloMarch 22, 2022
News Legalizing cannabis doesn’t raise youth use, shows study backed by industry coalition The lobbying group includes tobacco giant Altria and beer maker Molson Coors Nick LabaMarch 18, 2022
Business Canadian cannabis sales slow 2% in January to $347.2M Statistics Canada also significantly revised its December data to reflect less sales in that month Natalia Buendia CalvilloMarch 18, 2022
Business US and Canadian cannabis sales will hit new highs this 4/20: Headset The daily sales spike is steeper south of the border Natalia Buendia CalvilloMarch 17, 2022